Autogenous  ||| S:0 E:11 ||| JJ
bone  ||| S:11 E:16 ||| NN
with  ||| S:16 E:21 ||| IN
or  ||| S:21 E:24 ||| CC
without  ||| S:24 E:32 ||| IN
hydroxyapatite  ||| S:32 E:47 ||| JJ
bone  ||| S:47 E:52 ||| NN
substitute  ||| S:52 E:63 ||| NN
augmentation  ||| S:63 E:76 ||| NN
in  ||| S:76 E:79 ||| IN
rat  ||| S:79 E:83 ||| JJ
calvarium  ||| S:83 E:93 ||| NN
within  ||| S:93 E:100 ||| IN
a  ||| S:100 E:102 ||| DT
plastic  ||| S:102 E:110 ||| JJ
cap  ||| S:110 E:114 ||| NN
We  ||| S:114 E:117 ||| PRP
evaluated  ||| S:117 E:127 ||| VBD
the  ||| S:127 E:131 ||| DT
effect  ||| S:131 E:138 ||| NN
of  ||| S:138 E:141 ||| IN
autogenous  ||| S:141 E:152 ||| JJ
bone  ||| S:152 E:157 ||| NN
( ||| S:157 E:158 ||| -LRB-
AB ||| S:158 E:160 ||| NNP
)  ||| S:160 E:162 ||| -RRB-
and  ||| S:162 E:166 ||| CC
hydroxyapatite  ||| S:166 E:181 ||| JJ
bone  ||| S:181 E:186 ||| NN
( ||| S:186 E:187 ||| -LRB-
HA ||| S:187 E:189 ||| NNP
)  ||| S:189 E:191 ||| -RRB-
for  ||| S:191 E:195 ||| IN
the  ||| S:195 E:199 ||| DT
assessment  ||| S:199 E:210 ||| NN
of  ||| S:210 E:213 ||| IN
bone  ||| S:213 E:218 ||| NN
augmentation  ||| S:218 E:231 ||| NN
beyond  ||| S:231 E:238 ||| IN
the  ||| S:238 E:242 ||| DT
skeletal  ||| S:242 E:251 ||| JJ
envelope  ||| S:251 E:260 ||| NN
in  ||| S:260 E:263 ||| IN
the  ||| S:263 E:267 ||| DT
rat  ||| S:267 E:271 ||| JJ
calvarium ||| S:271 E:280 ||| NN
.  ||| S:280 E:282 ||| .
The  ||| S:282 E:286 ||| DT
calvaria  ||| S:286 E:295 ||| NN
of  ||| S:295 E:298 ||| IN
12  ||| S:298 E:301 ||| CD
rats  ||| S:301 E:306 ||| NNS
were  ||| S:306 E:311 ||| VBD
exposed  ||| S:311 E:319 ||| VBN
and  ||| S:319 E:323 ||| CC
2  ||| S:323 E:325 ||| CD
plastic  ||| S:325 E:333 ||| NN
caps  ||| S:333 E:338 ||| NNS
were  ||| S:338 E:343 ||| VBD
placed  ||| S:343 E:350 ||| VBN
with  ||| S:350 E:355 ||| IN
AB  ||| S:355 E:358 ||| NNP
and  ||| S:358 E:362 ||| CC
HA  ||| S:362 E:365 ||| NNP
or  ||| S:365 E:368 ||| CC
AB  ||| S:368 E:371 ||| NNP
alone  ||| S:371 E:377 ||| RB
in  ||| S:377 E:380 ||| IN
the  ||| S:380 E:384 ||| DT
calvarium ||| S:384 E:393 ||| NN
.  ||| S:393 E:395 ||| .
Images  ||| S:395 E:402 ||| NNS
of  ||| S:402 E:405 ||| IN
bone  ||| S:405 E:410 ||| NN
augmentation  ||| S:410 E:423 ||| NN
within  ||| S:423 E:430 ||| IN
the  ||| S:430 E:434 ||| DT
plastic  ||| S:434 E:442 ||| JJ
caps  ||| S:442 E:447 ||| NNS
were  ||| S:447 E:452 ||| VBD
taken  ||| S:452 E:458 ||| VBN
using  ||| S:458 E:464 ||| VBG
micro-CT  ||| S:464 E:473 ||| JJ
( ||| S:473 E:474 ||| -LRB-
R_mCT ||| S:474 E:479 ||| NNP
) ||| S:479 E:480 ||| -RRB-
.  ||| S:480 E:482 ||| .
Histologic  ||| S:482 E:493 ||| JJ
sections  ||| S:493 E:502 ||| NNS
were  ||| S:502 E:507 ||| VBD
cut  ||| S:507 E:511 ||| VBN
along  ||| S:511 E:517 ||| IN
the  ||| S:517 E:521 ||| DT
same  ||| S:521 E:526 ||| JJ
plane  ||| S:526 E:532 ||| NN
as  ||| S:532 E:535 ||| IN
those  ||| S:535 E:541 ||| DT
used  ||| S:541 E:546 ||| VBN
for  ||| S:546 E:550 ||| IN
the  ||| S:550 E:554 ||| DT
R_mCT  ||| S:554 E:560 ||| CD
images  ||| S:560 E:567 ||| NNS
at  ||| S:567 E:570 ||| IN
12  ||| S:570 E:573 ||| CD
weeks ||| S:573 E:578 ||| NNS
.  ||| S:578 E:580 ||| .
Bone  ||| S:580 E:585 ||| JJ
volume  ||| S:585 E:592 ||| NN
( ||| S:592 E:593 ||| -LRB-
BV ||| S:593 E:595 ||| NNP
)  ||| S:595 E:597 ||| -RRB-
was  ||| S:597 E:601 ||| VBD
calculated  ||| S:601 E:612 ||| VBN
using  ||| S:612 E:618 ||| VBG
BV-measuring  ||| S:618 E:631 ||| JJ
software ||| S:631 E:639 ||| NN
.  ||| S:639 E:641 ||| .
BV  ||| S:641 E:644 ||| NNP
increased  ||| S:644 E:654 ||| VBD
at  ||| S:654 E:657 ||| IN
both  ||| S:657 E:662 ||| PDT
the  ||| S:662 E:666 ||| DT
experimental  ||| S:666 E:679 ||| JJ
and  ||| S:679 E:683 ||| CC
control  ||| S:683 E:691 ||| NN
sites ||| S:691 E:696 ||| NNS
.  ||| S:696 E:698 ||| .
The  ||| S:698 E:702 ||| DT
newly  ||| S:702 E:708 ||| RB
generated  ||| S:708 E:718 ||| VBN
tissue  ||| S:718 E:725 ||| NN
did  ||| S:725 E:729 ||| VBD
not  ||| S:729 E:733 ||| RB
significantly  ||| S:733 E:747 ||| RB
differ  ||| S:747 E:754 ||| VB
between  ||| S:754 E:762 ||| IN
the  ||| S:762 E:766 ||| DT
experimental  ||| S:766 E:779 ||| JJ
and  ||| S:779 E:783 ||| CC
control  ||| S:783 E:791 ||| NN
sites ||| S:791 E:796 ||| NNS
;  ||| S:796 E:798 ||| :
however ||| S:798 E:805 ||| RB
,  ||| S:805 E:807 ||| ,
the  ||| S:807 E:811 ||| DT
mineralized  ||| S:811 E:823 ||| JJ
tissue  ||| S:823 E:830 ||| NN
was  ||| S:830 E:834 ||| VBD
significantly  ||| S:834 E:848 ||| RB
higher  ||| S:848 E:855 ||| JJR
at  ||| S:855 E:858 ||| IN
control  ||| S:858 E:866 ||| NN
sites  ||| S:866 E:872 ||| NNS
compared  ||| S:872 E:881 ||| VBN
with  ||| S:881 E:886 ||| IN
experimental  ||| S:886 E:899 ||| JJ
sites ||| S:899 E:904 ||| NNS
.  ||| S:904 E:906 ||| .
The  ||| S:906 E:910 ||| DT
results  ||| S:910 E:918 ||| NNS
indicate  ||| S:918 E:927 ||| VBP
that  ||| S:927 E:932 ||| IN
the  ||| S:932 E:936 ||| DT
combination  ||| S:936 E:948 ||| NN
of  ||| S:948 E:951 ||| IN
HA  ||| S:951 E:954 ||| NNP
and  ||| S:954 E:958 ||| CC
AB  ||| S:958 E:961 ||| NNP
was  ||| S:961 E:965 ||| VBD
biocompatible  ||| S:965 E:979 ||| JJ
and  ||| S:979 E:983 ||| CC
allowed  ||| S:983 E:991 ||| VBN
osteoconduction ||| S:991 E:1006 ||| NN
.  ||| S:1006 E:1008 ||| .
